244460 fundamentals
OLIPASS CORPORATION revenue breakdown overview
The greatest contribution to the revenue figure was made by South Korea — last year it brought OLIPASS CORPORATION 5.29 B KRW, and the year before that — 2.30 B KRW.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
1.50 B
3.00 B
4.50 B
6.00 B
Research
Biopharmaceuticals Product
Biopharmaceuticals Merchandise
Other
Service
Pharmaceuticals
Currency: KRW
2016
2017
2018
2019
2020
2021
2022
2023
Research
204.26 M
135.82 M
—
363.38 M
5.29 B
Biopharmaceuticals Product
1.41 B
2.68 B
685.46 M
1.87 B
—
Biopharmaceuticals Merchandise
20.32 M
23.66 M
2.29 M
8.19 M
—
Other
45.68 M
2.50 M
164.04 M
55.42 M
—
Service
25.69 M
20.10 M
—
—
—
Pharmaceuticals
—
—
—
—
—
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
1.50 B
3.00 B
4.50 B
6.00 B
South Korea
Currency: KRW
2016
2017
2018
2019
2020
2021
2022
2023
South Korea
1.71 B
2.86 B
851.78 M
2.30 B
5.29 B